Wuxi Biologics Unspadr2 Stock Net Income
| 1FW1 Stock | EUR 4.18 0.08 1.95% |
WUXI BIOLOGICS UNSPADR2 fundamentals help investors to digest information that contributes to WUXI BIOLOGICS's financial success or failures. It also enables traders to predict the movement of WUXI Stock. The fundamental analysis module provides a way to measure WUXI BIOLOGICS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WUXI BIOLOGICS stock.
WUXI |
WUXI BIOLOGICS UNSPADR2 Company Net Income Analysis
WUXI BIOLOGICS's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current WUXI BIOLOGICS Net Income | 1.69 B |
Most of WUXI BIOLOGICS's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WUXI BIOLOGICS UNSPADR2 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, WUXI BIOLOGICS UNSPADR2 reported net income of 1.69 B. This is 395.19% higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net income for all Germany stocks is 195.98% lower than that of the firm.
WUXI Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WUXI BIOLOGICS's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of WUXI BIOLOGICS could also be used in its relative valuation, which is a method of valuing WUXI BIOLOGICS by comparing valuation metrics of similar companies.WUXI BIOLOGICS is rated below average in net income category among its peers.
WUXI Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0551 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.31 % | |||
| Shares Outstanding | 2.11 B | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | 238.12 X | |||
| Revenue | 13.09 B | |||
| Gross Profit | 4.83 B | |||
| EBITDA | 4.6 B | |||
| Net Income | 1.69 B | |||
| Cash And Equivalents | 8.48 B | |||
| Cash Per Share | 4.15 X | |||
| Total Debt | 3.33 B | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 3.16 X | |||
| Book Value Per Share | 16.51 X | |||
| Cash Flow From Operations | 1.88 B | |||
| Earnings Per Share | 0.25 X | |||
| Number Of Employees | 10.59 K | |||
| Beta | 1.11 | |||
| Market Capitalization | 32.39 B | |||
| Z Score | 5.4 |
About WUXI BIOLOGICS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WUXI BIOLOGICS UNSPADR2's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WUXI BIOLOGICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WUXI BIOLOGICS UNSPADR2 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in WUXI Stock
WUXI BIOLOGICS financial ratios help investors to determine whether WUXI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WUXI with respect to the benefits of owning WUXI BIOLOGICS security.